There you go Real when you have nothing concrete to back up your positions you try and tear someone else down. A very sad individual.
I have not seen that post that you are a LT investor other than for your pumping the stock for your trading benefit. Who is going to believe you now anyway. I don' post fictional information , I may have been off a little or made an honest mistake as I am human.
I never recommended to sell when it was in the .30's I just stated it could go down and that was just my opinion. No one is right all the time. You and Real just try to discredit me for your own trading benefit. Hopefully the LT investors will get wise to you two now.
Here is Patrick's statement in an email this morning:
My fund has never lost $ in this stock. We made $ on it on 5 previous trades and we are up nicely on it now because I was buying aggressively in the .30s . How stupid to state that. I post to offset the pumping by the two of you and to provide fact to LT investors not to fall for the two you taking advantage of them..
So did you sell any of those shares already? We know Real sold 130K since in his own posts his last post said he held 500K shares and the previous post stated he held 630K.
So long term investors take note that their pumping is so they can make bank on their trades al the while LT investors suffer the ups and downs of the PPS.
5. Study: Migraine prevention wearable helps brain metabolic activity return to normal
By Stacy Lawrence Comment | Forward | Twitter | Facebook | LinkedIn
Cranial Nerve Stimulator--Courtesy of Cefaly
Belgium-based Cefaly Technologies already secured FDA approval for its headband-like device that stimulates the trigeminal nerve to reduce the frequency and intensity of migraines in March 2014. But now it has revealed Positron Emission Tomography (PET) scan data showing that its Cefaly device can aid areas of the brain in returning to their normal metabolic rate in migraine patients.
The European study looked at 28 patients who reported having at least four migraines per month. These patients were monitored over three months as they used Cefaly once a day for 20 minutes.
The idea was to better understand the short- and medium-term metabolic changes in the areas of the brain involved in migraine: the orbitofrontal cortex and the rostral cingulate, which are involved in decision-making and emotional behavior. In migraine patients, those areas of the brain tend to be sub-metabolic compared to people without migraines.
Researchers found via the PET imaging that use of the Cefaly device normalized the metabolic activity of the orbitofrontal cortex and rostral cingulate. These results were presented last month at the Euro Head Pain conference in Valencia, Spain.
"This is a major breakthrough in understanding the mechanism of action of the device on the central nervous system," said Cefaly CEO Dr. Pierre Rigaux in a statement. "It will help us take developments in this non-invasive, drug-free, technology even further."
He added, "The modifications observed through the PET scan reinforce the strong clinical data on safety and efficacy that led to the FDA approval."
The FDA approval was based upon randomized, double-blind clinical data from five university clinics in Belgium and a patient satisfaction study of more than 2,300 Cefaly users in France
So you don't hold long term, just like Real and that is why the PPS goes up and comes right back down due to you folks killing LT investors. Thank you for your honesty that all you do is pump to sell at a profit and leave the LT investors holding the bag. LT investors ought to head that warning and do the same to make money here.
I did not post to sell. I did say the PPS could very well go lower, Again you put words in my mouth. So you admit you came in to pump the stock. Really, not because your fund was losing money. What a crock. I am here to inform and because I was going to come back in at some point. Not sure now as the company again hasn't preformed to date, other than Edgemont finally selling ForFivo after 11/2 years not selling it. No one has explained why it took so long for them to promote the product.
Patrick I am sure you are right, but if they come up with more studies to back him up it could possibly happen. I didn't say this was a major development, just you as usual blaming me for saying something that I didn't. I post what I read to inform as every investor should know all the info they can to make the best investment decisions they can.
Medscape Medical News Psychiatry
'Stop Almost All Psychiatric Meds to Prevent Harm,' Expert Says
June 01, 2015
Maybe this could affect ForFivo or Pyschzo film?? Interesting at least.
Almost all psychotropic drugs could be stopped without causing any harm and with little loss of benefits, saving hundreds of thousands of lives and leading to happier and longer-lived populations, says a Danish expert in a head-to-head editorial debate.
Writing ahead of a debate in London over the use of psychiatric drugs, Peter C. Gøtzsche, MD, Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark, believes these medications offer few benefits compared with placebo and may cause more than half a million deaths per year in the United States and Europe.
Consequently, 98% of psychotropic drugs should be dropped. These include all antidepressant, attention-deficit/hyperactivity disorder, and dementia drugs and all but 6% of the antipsychotics and benzodiazepines currently in use.
Patrick you state you have been in IGXT stock for years, I think 5 or 6 that you stated, but your patrick38 has only been posting since Nov. 6 2014. Who were you before? Or did your company assign you to this stock to post to help promote it since it was in the 30's back then and your fund/company must have been losing a lot of bucks. There is always a reason for everything.
correction a 11/2 from now for suboxone approval. On migraine and they have to find a commercialization partner and with your view on migraine film it won't have a lot of sales, what partner would bother?
Patrick, you don't count the increase in rent and loan payments for the facility in your net income and cash flow analysis? You kidding me? They have stated they will be seeking 3rd party clients for the facility. Of course once they have a product approved they will make additional dollars through the facility, but that is 2 years out for suboxone and even according to you migraine will add little and it will be at least a year and 1/2 from now when it is approved and the facility should be ready a year from now. The $2m number is for the new supplier and not what they have to reimburse RedHill for their development costs for the higher percentage split with RedHill. You always leave out important details in your posts to promote your views. You say you are a hedge fund manager, but aren't even mentioned on the website for the company you work for. Remember IGXT's biggest fund sold most if not all of their shares recently at a loss, why would your company's returns be any better? The PPS speaks for itself. Investors know of ForFivo sales and milestones, but still the PPS is at .60. Only the company's future performance will reverse the company's past negative performance which s why the PPS is at .60, not over a $1 or $2 that you pumpers continue to post.
No I found I had to delete some of the article because it wouldn't fit. If you ever had anything to share you would find out the space isn't unlimited. I never cut out things to change the articles I post. You have a comprehension problem and this is a good example. I did not say a manufacturing facility was a bad thing. I posted things that you left out for your agenda. It is obviously a lot more complicated than you can comprehend, so maybe you should think before you post.
FYI, jgeorge did you also forget they have to get FDA to inspect the facility after it is completely built and completed a batch of film for them to give the facility approval. This will take at least 6 months after completion, then they have to find clients to produce product and hire personnel to run it and sell the manufacturing, with at least 4 other film producers already producing film. Oh, mortgage payments should be $57K a month or $672K a year, along with the new higher rent of $87,000 a year.
Real/Igxtnow one in the same. You too have two, but I think more. I only have two. I have stated that and you have acknowledged I have said in the long term I was positive on IGXT, but alas I changed my mind this week.I am very concerned IGXT won't preform differently than the past.
ETRM is just getting started selling their device, so sit back and see how well it does. You will be surprised.
You bash me for being invested in ETRM and it has gone down and not met my original targets, but IGXT has gone down from the $1.18 you were pumping to .50 now and you don't think you are a loser???? Think again. People in glass houses shouldn't throw stones.
ZZ I agree as I was invested in them years ago and visited their head qtr's in Brentwood and have followed them and their spin offs. DARA hasn't done well lately either. Well that is 3 for 3, pretty consistent. Better recheck your investment strategy.
Again you pontificate rather than answer the question of what will bring income until 2017. Par is known and from history of their partnerships the partner gets little and I have shown that with IPCI partnerships with Par and Par owns 121/2% of them, none of IGXT. Manufacturing facility is taking money the next two years and isn't a guaranteed money maker as there are other film manufacturers as competition and it has to be completed and approved by the FDA. ForFivo dollars are going to build the facility and is the only success to date even with the 11/2 years to start selling and significant amount. We will see if the additional 20 sales people will boost sales above the current level increases. You always forget this company has no credibility in the marketplace to get anything done and Horst is a terrible speaker that doesn't instill confidence either, that is why the PPS is where it is at and not going up with all the positives he eludes to and posters here keep pumping.
Patrick you are clueless and always miss the point. Migraine was only one example. Maybe you are schizo. They first have to get through the trials and with their record not get another CRL as they are 2 for 2 for those. That maybe the only consistent accomplishment they have done. Also there will be no partnership until it is approved a couple of years from now. What I stated was there is nothing major going to happen until at least 2017. Comment in that, rather than your normal mumbo, jumbo.